Antonio La Sala

ABVD Compared With BEACOPP Compared With CEC for the Initial Treatment of Patients With Advanced Hodgkin's Lymphoma: Results From the HD2000 Gruppo Italiano per lo Studio dei Linfomi Trial

Massimo Federico, Stefano Luminari, Emilio Iannitto et al. · Journal of Clinical Oncology · 2009 · 272 citations · Full text

Medicine, Oncology, Pharmacology +12

Darbepoetin alpha for the treatment of anaemia in low‐intermediate risk myelodysplastic syndromes

Pellegrino Musto, Francesco Lanza, Enrico Balleari et al. · British Journal of Haematology · 2004 · 97 citations · Full text

Medicine, Hematology, Pharmacology +12

Pamidronate Reduces Skeletal Events but does not Improve Progression-free Survival in Early-stage Untreated Myeloma: Results of a Randomized Trial

Angelo Michele Carella, Pellegrino Musto, Antonietta Falcone et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2003 · 52 citations

Medicine, Pharmacology, Pharmacotherapy +14

Efficacy of a single, weekly dose of recombinant erythropoietin in myelodysplastic syndromes

Pellegrino Musto, Antonietta Falcone, Grazia Sanpaolo et al. · British Journal of Haematology · 2003 · 49 citations · Full text

Medicine, Hematology, Pharmacology +12

Pamidronate Reduces Skeletal Events but does not Improve Progression-free Survival in Early-stage Untreated Myeloma: Results of a Randomized Trial

Pellegrino Musto, Antonietta Falcone, Grazia Sanpaolo et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2003 · 34 citations

Medicine, Pharmacology, Pharmacotherapy +14